10. Which people with type 2 diabetes would benefit from SGLT-2 inhibitors and GLP-1 receptor agonists?
ASCEND Talking Diabetes
English - November 25, 2020 10:00 - 11 minutes - 7.66 MBHealth & Fitness diabetes insulin diabetes management basal insulin hba1c hypoglycaemia ascend diabetes ascend talking diabetes talking diabetes ascend Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Next Episode: 4. Why should I treat more intensively earlier?
Listen to Professor Liebl outline when and how he uses these modern agents.
Learning objective: Following this activity, you will be able to confidently identify individuals in whom SGLT-2 inhibitors and GLP-1 receptor agonists are likely to be the preferred therapeutic option after metformin.